(Q38144914)

29 August 2017

title

Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice? (English)

1 reference

29 August 2017

0 references

coronary artery disease

1 reference

Johannes Mair

1

1 reference

29 August 2017

Allan S Jaffe

series ordinal

2

1 reference

29 August 2017

publication date

1 February 2014

1 reference

Molecular Diagnosis and Therapy

29 August 2017

published in

1 reference

29 August 2017

volume

18

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

5-15

1 reference

https://scigraph.springernature.com/pub.10.1007/s40291-013-0057-0

29 August 2017

exact match

0 references

cites work

Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Recent trends in the prevalence of coronary disease: a population-based autopsy study of nonnatural deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Progress and challenges in translating the biology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Atherosclerosis: current pathogenesis and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Widespread coronary inflammation in unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Angiographic lesion severity and subsequent myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Concept of vulnerable/unstable plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

A prospective natural-history study of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Epitope specificity and IgG subclass distribution of autoantibodies to cardiac troponin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Quantifying the accuracy of a diagnostic test or marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Quantifying the added value of a diagnostic test or marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Brief critical review: Statistical assessment of biomarker performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Race and gender differences in C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Prognostic value of myeloperoxidase in patients with chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Diurnal plasma concentrations of natriuretic propeptides in healthy young males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Pregnancy-associated plasma protein A values in patients with stable cardiovascular disease: use of a new monoclonal antibody-based assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Influence of common genetic variation on blood lipid levels, cardiovascular risk, and coronary events in two British prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Genes and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Bias in associations of emerging biomarkers with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Familial clustering of myocardial infarction in first-degree relatives: a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Clinical Utility of C-Reactive Protein Measured at Admission, Hospital Discharge, and 1 Month Later to Predict Outcome in Patients With Acute Coronary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Studies on the effects of heparin products on pregnancy-associated plasma protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

Recommendations for the use of cardiac troponin measurement in acute cardiac care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

How to use high-sensitivity cardiac troponins in acute cardiac care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0057-0

A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane

21 January 2018

1 reference

12 December 2020

Assessment of clinical performance without adequate analytical validation: A prescription for confusion

1 reference

12 December 2020

Neutrophil infiltration of culprit lesions in acute coronary syndromes

1 reference

12 December 2020

Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients

1 reference

12 December 2020

Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial

1 reference

12 December 2020

Increased plasma concentrations of soluble CD40 ligand in acute coronary syndrome depend on in vitro platelet activation

1 reference

12 December 2020

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

12 December 2020

Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence

1 reference

12 December 2020

C-reactive protein fifty years on

1 reference

12 December 2020

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation--performance and standardization: a background paper

1 reference

12 December 2020

Reference change values: the way forward in monitoring

1 reference

12 December 2020

The effect of sample hemolysis on cardiac troponin I and T assays

1 reference

12 December 2020

Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes

1 reference

12 December 2020

Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin

1 reference

12 December 2020

10.1007/S40291-013-0057-0

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1020775413

0 references

1 reference